Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

Sir Alec Shelbrooke said he has struggled with his weight throughout his life. A Conservative former minister said he has ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

TestoPrime is considered the best testosterone booster in 2025 because it has all-natural ingredients, a money-back guarantee ...

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration ...

Navigating the world of nutrition can feel like trying to find your way through a maze of myths and misconceptions. Before ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.